Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

SEC Form 4 filed by Chief Executive Officer Rawcliffe Adrian

ByQuantisnow·Wall Street's wire, on your screen.
ADAP· Adaptimmune Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.

SEC Form 4 filed by Chief Executive Officer Rawcliffe Adrian | Quantisnow